Big Data Key to Fighting Disease

A major part of this effort is now also being focused on improving the data about the impact that AMR is having on global health in a bid to convince policymakers that more needs to be done, and faster, to meet the challenge.

Key to this approach will be use of the Global Burden of Disease (GBD) project – a hugely influential epidemiological study that has mapped the worldwide impact of diseases and other health risks since the 1990s – to publish comprehensive data on how many people are being affected and being killed by drug-resistant infections.

Alan Lopez, a co-founder of the original study and now laureate professor at the University of Melbourne, said much like GBD data on lung cancer had helped to press home the case for governments to tackle smoking, incorporating AMR into the project could be vitally important.

Full story

About the Author

Comments are closed.